ArticleBMC rheumatology2026

Real-world outcomes of avacopan beyond the first year in antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study.

Makoto Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.